We examine the evidence for Coconut Oil as a treatment for Alzheimer’s, and look at the science behind the anecdotal claims.
Findings were reported today from the first phase III anti-tau drug in people with mild-to-moderate Alzheimer’s. The drug, called LMTM, was being tested in a 15-month double-blind, controlled trial in 891 people.
At the Alzheimer’s Research UK Conference 2016 in Manchester this week we’ve been hearing about some of the latest emerging research from across the UK.
The Alzheimer’s Research UK Drug Discovery Alliance is a £30m powerhouse of dementia treatment discovery at leading universities for dementia research.
Drug development takes time, and at Alzheimer’s Research UK we’ve been calling for policy change to help deliver breakthroughs for dementia treatment.